WO2017197255A1 - Insert et support pour empêcher la fatigue et la faiblesse du pied - Google Patents

Insert et support pour empêcher la fatigue et la faiblesse du pied Download PDF

Info

Publication number
WO2017197255A1
WO2017197255A1 PCT/US2017/032392 US2017032392W WO2017197255A1 WO 2017197255 A1 WO2017197255 A1 WO 2017197255A1 US 2017032392 W US2017032392 W US 2017032392W WO 2017197255 A1 WO2017197255 A1 WO 2017197255A1
Authority
WO
WIPO (PCT)
Prior art keywords
medial
foot
cutout
orthotic device
lateral
Prior art date
Application number
PCT/US2017/032392
Other languages
English (en)
Inventor
Richard Jay
Original Assignee
Richard Jay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richard Jay filed Critical Richard Jay
Publication of WO2017197255A1 publication Critical patent/WO2017197255A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
    • A43B7/1415—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot
    • A43B7/144—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form characterised by the location under the foot situated under the heel, i.e. the calcaneus bone
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
    • A43B17/02—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined wedge-like or resilient
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/24—Insertions or other supports preventing the foot canting to one side , preventing supination or pronation

Definitions

  • the flexible flatfoot describes a foot that has a normal arch during non-weight bearing conditions that collapses during stance or during other weight bearing conditions.
  • a biomechanical examination of the child is typically required, which includes measurements of the lower extremities from the hips to the toes or other techniques accepted by those having ordinary skill in the art. This examination typically includes tests in both open and closed chain kinetics and an analysis of the child's gait pattern.
  • Decreased ankle dorsiflexion with both the knee extended and flexed indicates a gastro- soleal equinus; while limited dorsiflexion with knee extended only, is indicative of gastrocnemius equinus. Limited ankle dorsiflexion can lead to compensatory and abnormal subtalar joint pronation and later, flexible flatfoot.
  • the forefoot to rearfoot relationship is important when evaluating the flexible flatfoot. This relationship is measured while the subtalar joint is in neutral and the midtarsal joint is locked on the rearfoot complex. In forefoot varus the forefoot is inverted to the sagittal bisection of the calcaneus, while in forefoot valgus, it is everted. Both are etiologies of flexible flatfoot. Embryological development, typically dictates that the foot is in an inverted position in utero and begins to evert at the sixteenth week. This eversion continues through the early childhood years but, the forefoot may not become fully plantar-grade in time for ambulation.
  • the resulting forefoot varus is compensated by pronation at the subtalar joint and subsequent eversion of the calcaneus. It has been estimated that an approximate four-degree (4 ° ) forefoot varus will cause maximal pronation at the subtalar joint by shifting the axis of body weight medially. For this reason, forefoot varus may be the most destructive cause of flexible flatfoot.
  • the abnormal pronatory motion or pronated position of the foot may be responsible for chronic low grade foot and postural
  • pronation which everts the calcaneus, is considered more pathological than that which allows the calcaneus to remain vertical during weight bearing.
  • the angle of the posterior vertical axis of the calcaneus to the supporting surface, during stance, is called the relaxed calcaneal stance position ("RCSP").
  • the RCSP is a measurement that indicates the position of the calcaneus in the frontal plane after all compensatory pronation has taken place at the subtalar joint. In essence, this measurement is a quick method to scientifically determine the amount of pronation that is present in a given foot.
  • the normal foot, while relaxed instance, should have a bisection of the posterior surface of the calcaneus that is perpendicular to the supporting surface. If the calcaneus is inverted to the transverse plane then it is considered to be in varus, if it is everted then it is in valgus.
  • One of the criteria set forth for flatfoot includes relaxed calcaneal valgus.
  • preferred embodiments of the present invention relate to an orthopedic device for the prevention of excess pronation in children and adults.
  • Excess pronation or flattening of the longitudinal arch of the foot is associated with the development of problems intrinsic to the foot such as heel spurs, bunions and hammertoes as well as symptoms extrinsic to the foot such as knee pain and low back pain.
  • the shoe wear industry has attempted through corrective shoes to control some of the excess pronation of certain users. Insert modifications as well as heel modifications, such as the Thomas heel, have been utilized for years but have been relatively ineffective.
  • the development of an in-shoe modification based upon biomechanical principles and design can control excess pronation and prevent or limit symptoms from developing in a large percentage of the patient population. With the adult and child population world-wide being extremely active, there is a high incidence of lower extremity fatigue and weakness secondary to excess pronation.
  • goals of the pediatric orthotic may include: (a) reduction of discomfort;
  • Orthotic therapy for the pediatric flatfoot is based upon a simple premise.
  • foot function improves and deforming forces are limited. For this reason, it is essential that excessive pronation be neutralized as soon as a child is old enough to stand.
  • the goals are to improve the child's function and to prevent future foot problems associated with flatfoot.
  • Some of the problems associated with flatfoot are painful heel spurs, bunions and hammertoes.
  • a device that can be placed within the shoe (include the above shoe types) and be removable.
  • Preferred embodiments of the present invention relate to an early age insert support that fosters healthy posture, foot alignment and stability in the crucial early years of a child's growth, as well as relating to the adult version of the insert support.
  • the insert according to preferred embodiments of the present invention is designed to help prevent and improve fatigue, painful foot ailments and provide on-going support for the adult and as a child's foot grows.
  • Another aspect of the preferred embodiments of the present invention relate to a shoe product comprising the insert support.
  • the preferred embodiments of the present invention further relate to a method of preventing foot fatigue or improving a child's foot function.
  • the method comprises providing the child a shoe product comprising an insert support according to a preferred embodiment of the present invention.
  • the preferred present invention is directed to an orthotic device for preventing or limiting hyperpronation in a the child and adult population.
  • the orthotic device includes a heel seat, medial and lateral flanges and medial and lateral pads associated with the medial and lateral flanges.
  • the heel seat is configured for substantially
  • the heel seat is laterally tilted at an acute angle and configured to leave the calcaneus in an approximate two to three degree inversion. Edges of the heel seat extend along sides of the foot.
  • the medial and lateral flanges are attached to the heel seat.
  • the medial and lateral flanges are configured to extend along sides of the foot along sides of at least portions of the first and fifth metatarsals of the foot, respectively.
  • the heel seat, the medial flanges and the lateral flanges are configured to stabilize the foot and limit end range motion in sagittal, frontal and transverse planes.
  • the medial and lateral pads are associated with the medial and lateral flanges and define a cutout therebetween. The cutout is positioned at least partially on a longitudinal axis of the orthotic device.
  • the preferred present invention is directed to an orthotic device for preventing or limiting hyperpronation in a foot having a calcaneus and a forefoot.
  • the orthotic device includes a heel seat, medial and lateral flanges attached to the heel seat and medial and lateral pads associated with the medial and lateral flanges.
  • the heel seat is configured for substantially surrounding a lower side of the calcaneus.
  • the heel seat is also configured to leave the calcaneus in an approximate two to three degree inversion. Edges of the heel seat extend along sides of the foot.
  • the medial and lateral flanges are configured to extend along sides of the foot along sides of at least portions of the first and fifth metatarsals of the foot, respectively.
  • the heel seat, the medial flanges and the lateral flanges are configured to stabilize the foot and limit end range motion in sagittal, frontal and transverse planes.
  • the medial and lateral pads define a cutout therebetween. The cutout is positioned at least partially on a longitudinal axis of the orthotic device.
  • the medial pad defines a medial pad length measured substantially parallel to the longitudinal axis and the lateral pad defines a lateral pad length measured substantially parallel to the longitudinal axis.
  • the lateral pad length is greater than the medial pad length.
  • FIG. 1 is a front perspective view from a medial aspect of an insert support in accordance with a first preferred embodiment of the present invention
  • FIG. 2 is a top perspective view of the insert support of Fig. 1 ;
  • Fig. 2A is a cross-sectional view of the insert support of Fig. 1, taken along line 2A-2A of Fig. 2;
  • Fig. 3 is a bottom perspective view of the insert of Fig. 1 ;
  • Fig. 3 A is a bottom plan view of an alternative embodiment of the insert of Fig. 1 ;
  • Fig. 4 is a top plan view of the insert of Fig. 1, wherein the insert is positioned within a shoe;
  • FIG. 5 is a side perspective view of an insert support in accordance with a second preferred embodiment of the present invention.
  • Fig. 6 is a top perspective view of the insert of Fig. 5;
  • Fig. 6A is a cross-sectional view of the insert support of Fig. 5, taken along line 6A-6A of Fig. 6;
  • Fig. 7 is a bottom perspective view of the insert of Fig. 5. DETAILED DESCRIPTION OF THE INVENTION
  • a pediatric and adult insert support 10, 10' are comprised of orthopedic devices that control hyperpronation or generally provide stability to the user's foot and leg.
  • a first preferred insert support or a pediatric insert support 10 is generally designed for use by the pediatric patient population.
  • a second preferred insert support or an adult insert support 10' is generally designed and constructed for use by the adult patient population.
  • the preferred pediatric and adult insert supports 10, 10' are described herein utilizing the same reference numerals to identify similar features between the two embodiments, with a prime symbol (') utilized to distinguish the features of the adult insert support 10' from the pediatric insert support 10.
  • the insert supports 10, 10' prevent or limit hyperpronation of the foot by substantially controlling all three planes of motion at the subtalar (above the heel) and midtarsal (posterior of the tarsals and anterior of the talus) joints.
  • the preferred insert supports 10, 10' accommodate structural deformity and protect the foot during growth or during normal use with materials that create a secure foot-orthotic interface.
  • the insert supports 10, 10' according to first and second preferred embodiments of the present invention or the pediatric insert support 10 and the adult insert support 10', are fitted with a two to three degree (2-3 ° ) varus inverted heel post F, F', which pitches the heel of the foot medially to stabilize the intrinsic bones and works to limit calcaneal eversion in the frontal plane and subsequent hyperpronation at the subtalar joint. This further prevents the foot to flatten or pronate into an abnormal position that will create pain and deformity.
  • the varus inverted heels F, F' may have a height of two to three centimeters (2-3 cm), but are not so limited and may have smaller or greater heights, based on patient or clinical need.
  • the pediatric and adult insert supports 10, 10' also have a heel cushion E, E', which prevents or limits injury to the heel growth plate and restores proper postural alignment of the foot.
  • the heel cushion E, E' is preferably located in the heel seat A, A' and is positioned proximate the calcaneus when the foot is positioned on the orthotic device 10, 10' in the working or mounted configuration.
  • the pediatric and adult insert supports or orthopedic devices 10, 10' also have a cutout D, D' positioned between a medial pad 12, 12' and a lateral pad 14, 14'.
  • the cutouts D, D' are preferably defined by the medial and lateral pads 12, 12', 14, 14'.
  • the medial pad 12, 12' is preferably configured to support at least the first ray of the foot and the lateral pad 14, 14' is preferably configured to support at least the fifth rays of the foot.
  • the medial and lateral pads 12, 12', 14, 14' are also configured to allow independent motion during the gait cycle and restore proper postural alignment of the foot.
  • the cutouts D, D' are positioned approximately three to seven centimeters (3-7 cm) from the distal edge of the insert supports 10, 10', but are not so limited an may be positioned at a greater or less distance from the distal edge, but are preferably positioned on or along a longitudinal axis Z, Z' of the insert supports 10, 10'.
  • the medial and lateral pads 12, 12', 14, 14' therefore, preferably have a width of three to seven centimeters (3-7 cm), but are not so limited and may be wider or narrower depending on the size of the preferred insert supports 10, 10', the preferred size of the cutouts D, D' and other factors related to the preferred design.
  • the adult version of the insert support 10' has the split cutout D' positioned over a forefoot extension G' of the insert support 10' (Figs. 5-7).
  • the forefoot extension G' preferably extends beyond a distal or forefoot end of the cutout D' and the medial and lateral pads 12', 14'.
  • the cutout D, D' is preferably positioned on or centered along the
  • the cutout D, D' preferably has a cutout length L, L' and a cutout width W, W and the insert supports 10, 10' preferably have a forefoot width WF, WF' at the forefoot end.
  • the forefoot width WF, WF' is preferably measured substantially perpendicular relative to the longitudinal axis Z, Z'.
  • the cutout length L, L' is approximately three to seven centimeters (3-7 cm) from the distal insert edge
  • the cutout width W, W is approximately two and one-half centimeters (21 ⁇ 2 cm) wide at its cutout distal end and preferably tapers to a three-quarter centimeter (3 ⁇ 4 cm) width at its cutout proximal end
  • the forefoot width WF, WF' is sized based approximately on the size of the patent's or user's foot.
  • the cutout width W, W preferably tapers from its cutout distal end width to the cutout proximal end width.
  • Each of these preferred dimensions is not limiting and may be modified based on patient or clinical need.
  • the cutout width W, W is preferably measured substantially perpendicular to the longitudinal axis Z, Z'.
  • the cutout D, D' is preferably positioned on the longitudinal axis Z, Z' and is substantially centered along the longitudinal axis Z, Z' in the preferred embodiments, but is not so limited and may be arranged in an offset arrangement relative to the longitudinal axis Z, Z' depending on patient anatomy and designer or medial professional preferences.
  • the pediatric insert support 10 is comprised of a left-foot support 10 wherein the medial and lateral pads 12, 14 terminate anteriorly or distally at substantially the same length L along the longitudinal axis Z.
  • the pediatric insert support 10 is comprised of a right-foot support 10, wherein the medial pad 12 extends further distally along the longitudinal axis Z than the lateral pad 14.
  • the alternative pediatric insert support 10 accordingly, defines a medial pad length L M and a lateral pad length LL, wherein the medial pad length LM is greater than the lateral pad length LL.
  • the medial and lateral pad lengths L M , L L are preferably measured substantially parallel to the longitudinal axis Z.
  • the alternative preferred insert support 10 is not limited to having the medial pad length L M being greater than the lateral pad length L L and may be configured with the lateral pad length L L being greater than the medial pad length L M or may be configured similar to the first preferred insert support 10 with the lateral and medial pad lengths L L , L M , being substantially the same.
  • the lateral pad length L L is approximately one and one-quarter to two (1 1 ⁇ 4 - 2) times greater than the medial pad length L M .
  • the lateral pad length L L may be approximately one and one-half inches (1 1 ⁇ 2") and the medial pad length L M may be approximately one and eight hundredths inches (1.08").
  • the medial and lateral pad lengths L L , L M are not limited to having these non-limiting example dimensions and may be otherwise sized and configured to conform to the size and shape of the patient's foot based on designer and medical professional preferences.
  • the medial and lateral pads 12', 14' have medial and lateral pad lengths L M ', L L L ' that are designed and configured similarly to the lateral and medial pad lengths L L , L M of the first preferred embodiment and are measured substantially parallel to the longitudinal axis Z'.
  • the pediatric and adult insert supports 10, 10' are also equipped with relatively high medial flanges B, B' and relatively high lateral flanges C, C, as seen in Fig. 1, 4 & 5.
  • the medial and lateral flanges B, B', C, C are attached to the heel seat A, A'.
  • the medial flanges B, B', lateral flanges C, C and heel seat A, A' preferably have a height H, H' of approximately two to three centimeters (2-3 cm), but may be smaller or larger, depending on patient or clinical need and may have the same, similar or a different height when compared to the medial flanges B, B'.
  • the flanges B, B', C, C generally prevent or limit movement along the transverse plane relative to the insert supports 10, 10' by preventing or limiting abduction of the forefoot at the mi dtarsal joint ("MTJ") and the spreading of the metatarsals, which both occur secondary to pronation at the subtalar joint ("STJ").
  • the deep heel seat A, A' preferably has the height H, H' of two to three centimeters (2-3 cm), but is not so limited and may have smaller to greater heights based on a particular patient or clinical need.
  • the medial flange B, B' provides support to the medial arch of the foot and inhibits flattening in the sagittal plane.
  • the preferred medial flange B, B' has the height H, H' of approximately two to three centimeters (2-3 cm), but is not so limited and may have a smaller or greater height based on clinical need or patient need.
  • the height H, H' of the medial flange B, B' is preferably, substantially the same as the height H, H' of the deep heel seat A, A', at least where the two components meet at the rear corners of the pediatric and adult insert supports 10, 10'.
  • the deep heel seats A, A' are preferably constructed of a relatively dense and semi-rigid material to a relatively flexible material that is able to take on the general size and shape of the deep heel seat A, A', withstand the normal operating conditions of the deep heel seat A, A' and perform the preferred functions of the deep heel seat A, A', as is described in detail herein.
  • the height H, H' of the medial and lateral flanges B, B', C, C also preferably taper downwardly as they extend toward a distal end of the medial and lateral pads 12, 12', 14, 14', respectively.
  • the deep heel seat A is laterally tilted and leaves the calcaneus in an approximate two to three-degree (2-3 ° ) inversion.
  • the deep heel seat A preferably defines an acute angle ⁇ to accommodate the tilt that is measured relative to a substantially horizontal plane P.
  • the heel seat A is not limited to defining the acute angle ⁇ , but preferably includes the acute angle ⁇ to address the patient's hyperpronation.
  • certain preferred inserts 10, 10' may be able to bring an average Resting Calcaneal Stance Position ("RCSP") of approximately six degrees (6°) of valgus to neutral.
  • RCSP Resting Calcaneal Stance Position
  • This orthotic is beneficial to children generally ages two to sixteen (2-16) years old, because, as the foot is held in alignment, the relationships of immature bones and joints are allowed to optimally develop.
  • the preferred pediatric insert supports 10, 10' not only serve to limit pediatric flatfoot symptoms but also works to prevent painful symptoms from occurring in adulthood.
  • the preferred orthotic devices 10, 10' both preferably define the acute angle, ⁇ , ⁇ ' such that the heel seat A, A' is laterally tilted and configured to leave the calcaneus in an approximately two to three-degree (2-3°) inversion. Edges of the heel seat A, A' preferably extend along sides of the foot, along with the medial and lateral flanges B, B', C, C to support the patient's foot in the mounted or working configuration and to limit end range motion in sagittal, frontal and transverse planes.
  • the medial and lateral flanges B, B', C, C are also configured to extend along sides of the foot in the mounted configuration, preferably along sides of at least portions of the first and fifth metatarsals of the foot, respectively.
  • the deep heel seats A, A' preferably define the acute angle ⁇ , ⁇ ' to accommodate the tilt that is measured relative to the substantially horizontal plane P.
  • the heel seat A, A' is not limited to defining the acute angle ⁇ , ⁇ ', but preferably includes the acute angle ⁇ , ⁇ ' to address the patient's hyperpronation.
  • the acute angle ⁇ , ⁇ ' is also not limited to being comprised of a two to three-degree (2-3°) angle and may include larger angles, such as five degrees (5°) or ten degrees (10°) for corrective purposes or smaller angles, such as one degree (1°) for more subtle correction or maintenance of the patient's condition.
  • Custom molded rigid orthotics for small children can become problematic because their feet are constantly growing. This problem may be approached by production of shoe gear that contains a built-in, lightweight, molded insert that corresponds to the size of the shoe and thus the foot. Rubber orthotics or insoles of similar materials are preferably firm enough to resist compression and prevent abnormal arch depression while maintaining normal posting values are excellent examples of suitable materials for children.
  • the insert supports 10, 10' can be made of varying durability, strength and stiffness materials, including polymeric materials, such as ethylene vinyl acetate ("EVA").
  • EVA ethylene vinyl acetate
  • Shoes containing built-in EVA pediatric and adult insert supports 10, 10' are preferably constructed using methods in view of the present disclosure such that the insert supports 10, 10' are able to take on the general size and shape of the preferred insert supports 10, 10', withstand the normal operating conditions of the insert supports 10, 10' and function in the preferred manner of the insert supports 10, 10', as is described herein. Any child old enough to stand, preferably after the age of two (2) years, to prevent foot fatigue and improve foot function, may wear the shoes, with the preferred insert supports 10 inserted or built into the child's shoes.
  • the insert supports 10, 10' can be clearly marked, e.g., by a green branded medallion, in the shoe.
  • the shoe box containing the shoe can also be clearly marked, e.g., by a sticker. This will let the parents or users know that their children's or their own feet are Good to Grow or are associated with the shoes that the user is purchasing or wearing.
  • the preferred orthotic devices or pediatric or adult insert supports 10, 10' are designed and configured for limiting hyperpronation in the patient's foot.
  • the preferred orthotic devices 10, 10' are specifically designed and configured to support and align the patient's lower extremities, specifically containing and supporting the calcaneus or heel bone of the patient's foot.
  • the patient's foot also includes the forefoot, which is typically considered to include the anterior aspect of the foot having the five metatarsal bones, the fourteen phalanges and associated soft tissue structures.
  • the heel seat A, A' substantially surrounds or contains a lower side of the calcaneus.
  • the preferred orthotic devices or inserts 10, 10' are configured to reduce fatigue and weakness to muscles of the foot and create a substantially constant secure foundation by limiting excess pronation.
  • the orthotic devices or inserts 10, 10' may be configured for a child or an adult to include a varus inverted heel or heel pad A, A' having the acute angle A, A' of approximately 2-3 degrees (2-3°) or other acute angles A, A', as was described in greater detail above.
  • the heel cushion E, E' is preferably associated with a bottom of the inserts 10, 10' to provide support for the patient's heel bone or calcaneus.
  • the cutout D, D' is preferably positioned forwardly relative to the heel cushion E, E', which is positioned within the heel pad A, A'.
  • the orthotic devices or inserts 10, 10' are preferably designed and configured for insertion or integral assembly with a shoe S.
  • the shoe S may be any type and variety of shoe for adult or pediatric use, such as a casual shoe, sneaker, dress shoe, running shoe, walking shoe, boot, sandal, loafer, wedges, clogs, heels or other shoe S.
  • the orthotic devices or inserts 10, 10' preferably prevent foot fatigue in a child or an adult, by providing to the foot of the adult and child, a shoe S or over-the- counter insert 10, 10', as was described above.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Le Proact and Growthotic est un insert et un support en vente libre (orthopédique) pour empêcher la fatigue et la faiblesse du pied du pied de l'enfant et du pied de l'adulte. Le support d'insert favorise une posture saine, l'alignement et la stabilité du pied pendant les premières années essentielles de la croissance et du développement d'un enfant et maintient le positionnement du pied de l'adulte en réduisant la fatigue et la faiblesse en luttant contre la pronation. Contrairement aux produits qui se concentrent sur le traitement de la douleur, le support d'insert et le support en vente libre sont conçus pour aider à empêcher la progression de pathologies du pied associées à la douleur.
PCT/US2017/032392 2016-05-12 2017-05-12 Insert et support pour empêcher la fatigue et la faiblesse du pied WO2017197255A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662335181P 2016-05-12 2016-05-12
US62/335,181 2016-05-12

Publications (1)

Publication Number Publication Date
WO2017197255A1 true WO2017197255A1 (fr) 2017-11-16

Family

ID=60267396

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/032392 WO2017197255A1 (fr) 2016-05-12 2017-05-12 Insert et support pour empêcher la fatigue et la faiblesse du pied

Country Status (1)

Country Link
WO (1) WO2017197255A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3653180A1 (fr) * 2018-11-17 2020-05-20 Ortopedia Ciaglia Srl Orthétique pour le contrôle du pied chez les personnes présentant des déficiences neuromusculaires mineures ou modérées
CN112869291A (zh) * 2021-01-05 2021-06-01 福建省嘉辰体育用品有限公司 一种成长期扁平足矫治鞋的制备工艺
DE202023106974U1 (de) 2023-11-24 2024-01-15 Fuß-Orthopädie Bermes Inh. Andreas Blau-Bermes e.K. Vorrichtung zur Entlastung der Ferse

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4759136A (en) * 1987-02-06 1988-07-26 Reebok International Ltd. Athletic shoe with dynamic cradle
US4813159A (en) * 1987-05-13 1989-03-21 Weiss Robert F Foot support for optimum recovery
US5174052A (en) * 1991-01-03 1992-12-29 Schoenhaus Harold D Dynamic stabilizing inner sole system
US5669162A (en) * 1996-03-07 1997-09-23 Brown Group, Inc. Cushion insert
US5842294A (en) * 1996-02-28 1998-12-01 Dr. Fabricant's Foot Health Products Inc. Golf orthotic
US20010000369A1 (en) * 1995-11-17 2001-04-26 Snyder Daniel B. Insole
US6973743B1 (en) * 2002-12-10 2005-12-13 Tom Mowery Gold shoe insole insert
US20080072461A1 (en) * 2006-09-21 2008-03-27 Howlett Harold A Cushioned orthotic
US20090094861A1 (en) * 2006-06-09 2009-04-16 Kevan Orvitz Orthopedic foot appliance
US20120233877A1 (en) * 2011-03-18 2012-09-20 Columbia Sportswear North America, Inc. High-stability multi-density midsole
US20150201702A1 (en) * 2012-03-01 2015-07-23 Spenco Medical Corportion Insole for Relief of Over-Pronation and Knee Joint Stress

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4759136A (en) * 1987-02-06 1988-07-26 Reebok International Ltd. Athletic shoe with dynamic cradle
US4813159A (en) * 1987-05-13 1989-03-21 Weiss Robert F Foot support for optimum recovery
US5174052A (en) * 1991-01-03 1992-12-29 Schoenhaus Harold D Dynamic stabilizing inner sole system
US20010000369A1 (en) * 1995-11-17 2001-04-26 Snyder Daniel B. Insole
US5842294A (en) * 1996-02-28 1998-12-01 Dr. Fabricant's Foot Health Products Inc. Golf orthotic
US5669162A (en) * 1996-03-07 1997-09-23 Brown Group, Inc. Cushion insert
US6973743B1 (en) * 2002-12-10 2005-12-13 Tom Mowery Gold shoe insole insert
US20090094861A1 (en) * 2006-06-09 2009-04-16 Kevan Orvitz Orthopedic foot appliance
US20080072461A1 (en) * 2006-09-21 2008-03-27 Howlett Harold A Cushioned orthotic
US20120233877A1 (en) * 2011-03-18 2012-09-20 Columbia Sportswear North America, Inc. High-stability multi-density midsole
US20150201702A1 (en) * 2012-03-01 2015-07-23 Spenco Medical Corportion Insole for Relief of Over-Pronation and Knee Joint Stress

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3653180A1 (fr) * 2018-11-17 2020-05-20 Ortopedia Ciaglia Srl Orthétique pour le contrôle du pied chez les personnes présentant des déficiences neuromusculaires mineures ou modérées
CN112869291A (zh) * 2021-01-05 2021-06-01 福建省嘉辰体育用品有限公司 一种成长期扁平足矫治鞋的制备工艺
DE202023106974U1 (de) 2023-11-24 2024-01-15 Fuß-Orthopädie Bermes Inh. Andreas Blau-Bermes e.K. Vorrichtung zur Entlastung der Ferse

Similar Documents

Publication Publication Date Title
Postema et al. Primary metatarsalgia: the influence of a custom moulded insole and a rockerbar on plantar pressure
Leung et al. Biomechanical gait evaluation of the immediate effect of orthotic treatment for flexible flat foot
Chen et al. Effects of foot orthoses on gait patterns of flat feet patients
Atik et al. Flexible flatfoot
US4676801A (en) Foot orthosis and process
US7849610B2 (en) Orthopedic shoe appliance and method
US6874258B2 (en) Orthopedic shoe appliance and method
Tang et al. The effects of total contact insole with forefoot medial posting on rearfoot movement and foot pressure distributions in patients with flexible flatfoot
Turner et al. A guide to the management of paediatric pes planus
WO2017197255A1 (fr) Insert et support pour empêcher la fatigue et la faiblesse du pied
Garbalosa et al. The effect of orthotics on intersegmental foot kinematics and the EMG activity of select lower leg muscles
Landorf et al. Efficacy of foot orthoses: what does the literature tell us?
Doxey Clinical use and fabrication of molded thermoplastic foot orthotic devices: suggestion from the field
Steb et al. Conservative management of posterior tibial tendon dysfunction, subtalar joint complex, and pes planus deformity
RU61549U1 (ru) Голеностопный ортез
Bakhtiari et al. Effects of Custom-mold Insole by Medial Heel Skive Technique on Physical Function in Flexible Flat Foot
Balasankar et al. Common foot and ankle disorders in adults and children
Taylor Idiopathic flexible flatfoot in the adolescent
RU132720U1 (ru) Ортопедическая стелька для лечения плоско-вальгусной деформации стопы у детей
Manjima et al. A Review On Paada Sharir With Special Reference To Deformities Of Medial Longitudinal Arch Of Foot
Bednarczyk et al. Understanding flat feet: An in-depth analysis of orthotic solutions
Suh et al. Comparing the effects of University of California Biomechanics Laboratory and custom-made semi-rigid insole on pedobarographic parameters in pediatric flexible flat foot
Ng Foot problems and their implications for footwear design
Zarezadeh et al. Effect of orthopedic shoe and functional foot orthosis on static equilibrium in flexible flat foot juvenile
Dolan The Use of Foot Orthotic Devices in Clinical Practice.

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17796931

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17796931

Country of ref document: EP

Kind code of ref document: A1